Z-1636-2024 Class II Ongoing

Recalled by Quidel Corporation — San Diego, CA

FDA device recall Z-1636-2024 was initiated by Quidel Corporation on Mar 5, 2024 and is designated Class II. Reason for recall: There are two windows on the test device, the control line window and the test results window. The line for the test results window were misaligned. In instances of positive test results, the… The recall status is ongoing. Affected quantity: 104,300 units.

Recall details

Product Type
Devices
Report Date
May 1, 2024
Initiation Date
Mar 5, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
104,300 units

Product description

QUIDEL InflammaDry MMP-9 Test, REF: PRS-ID-20-U, 20 Tests

Reason for recall

There are two windows on the test device, the control line window and the test results window. The line for the test results window were misaligned. In instances of positive test results, the positivite test line may not be visible/ hidden under the cassette of the test device thus potentially leading to a false negative result.

Distribution pattern

US: AK AL AR AZ CA CO CT DC FL GA HI IA ID IL IN KS KY LA MA MD MI MN MO MT NC ND NE NH NJ NV NY OH OK OR PA SC SD TN TX UT VA WA WI WV OUS: United Arab Emirates, Belgium, Canada, Chile, China, Germany, Spain, United Kingdom, Ireland, Italy, South Korea, Lithuania, Qatar

Code information

UDI: 30014613336754/Lot # 162621 162695 162498 162718 162749 163025

Source

Dataset
openFDA device recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for Z-1636-2024
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for Z-1636-2024. Report a data issue: hello@regdatalab.com.